Cardica Names Frederick Bauer Vice President of Operations

    REDWOOD CITY, Calif., July 17 /EMWNews/ -- Cardica, Inc.

(Nasdaq: CRDC) today announced the appointment of Frederick Bauer to the

position of vice president, operations. Mr. Bauer brings more than 30 years

of national and international operations and manufacturing experience to

Cardica from large healthcare organizations including Medtronic and Baxter

Healthcare.



    "Fred's extensive operations experience and his continuous drive to

improve quality and performance will be of tremendous value to Cardica as

we continue to expand our manufacturing capability to meet the increasing

demand for our C-Port(R) systems and plan the launch of our PAS-Port(R)

Proximal Anastomosis System later this year, subject to receiving 510(k)

clearance," said Bernard A. Hausen, M.D., Ph.D., president and chief

executive officer of Cardica.



    Previously, Mr. Bauer served as vice president of operations for the

cardiac surgery division of Medtronic, Inc., where he implemented key

manufacturing processes to improve productivity and reduce costs. Prior to

the cardiac surgery division, he was vice president of perfusion systems

for Medtronic, responsible for cardiopulmonary device manufacturing and

operations. Prior to his tenure at Medtronic, he held a variety of

positions at Baxter Healthcare International, including corporate vice

president of operations technology, vice president of operations for drug

administration and director of manufacturing services. In addition to his

medical device experience, he served as president of 3RLatex, a liquid

recycling company for construction sites and as general manager of Amazon

Environmental, a paint recycling company. Under Mr. Bauer's leadership, his

organizations have received numerous awards including the Medtronic Star of

Excellence and the Baxter Quality Award. Mr. Bauer received his bachelor of

civil engineering from the University of Detroit Mercy.

    About Cardica



    Cardica is a leading provider of automated anastomosis systems for

coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures

with easy-to-use automated systems, Cardica's products provide

cardiovascular surgeons with rapid, reliable and consistently reproducible

anastomoses, or connections of blood vessels, often considered the most

critical aspect of the CABG procedure. Cardica's C-Port(R) Distal

Anastomosis Systems are marketed in Europe and the United States. The

PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan,

and Cardica has submitted a 510(k) premarket notification for clearance to

market the PAS-Port system in the United States. Cardica also is developing

additional devices with Cook Medical to facilitate vascular closure and

other surgical procedures.



    Forward-Looking Statements



    This press release contains "forward-looking" statements, including

statements relating to expansion of Cardica's manufacturing capability,

increasing demand for the C-Port(R) Distal Anastomosis System and 510(k)

clearance and the planned launch of the PAS-Port System. Any statements

contained in this press release that are not historical facts may be deemed

to be forward-looking statements. The phrases and words "will be," and

"continue" or similar expressions are intended to identify forward-looking

statements. There are a number of important factors that could cause

Cardica's results to differ materially from those indicated by these

forward-looking statements, including risks associated with the scaling of

our operations, customer demand, and receipt of regulatory approvals, as

well as other risks detailed from time to time in Cardica's SEC reports,

including its Quarterly Report on Form 10-Q for the quarter ended March 31,

2008. Cardica does not undertake any obligation to update forward-looking

statements.